Several biotechnology companies announced plans to present at Canaccord Genuity’s 45th Annual Growth Conference, which opens in Boston on 12 August 2025. The firms include Compass Pathways, Satellos, Adicet Bio and Alnylam Pharmaceuticals, underscoring continuing investor interest in novel therapies across neuroscience, regenerative medicine and RNA-interference. Alnylam, the most mature of the group, said its management will deliver a company overview at 8:00 a.m. Eastern time, with a live webcast available on its investor website and a replay posted within 48 hours. The conference has historically drawn a broad mix of growth-oriented life-sciences companies and institutional investors, and this year’s line-up suggests sustained capital-markets engagement despite market volatility.